Citation Impact
Citing Papers
Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells
2012
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Signalling and survival pathways in multiple myeloma
2006
Patient-Specific 3D Microfluidic Tissue Model for Multiple Myeloma
2013
Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics
2008
The MRP family of drug efflux pumps
2003
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
2010
Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy
2004
Cotransport of Reduced Glutathione With Bile Salts by Mrp4 (Abcc4) Localized to the Basolateral Hepatocyte Membrane
2003
Immunotherapy of cancer in 2012
2012
Characterization of the Transport of Nucleoside Analog Drugs by the Human Multidrug Resistance Proteins MRP4 and MRP5
2003
The regulation of IL-10 production by immune cells
2010 Standout
Effluxing ABC transporters in human corneal epithelium
2009
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Preoperative Systemic Inflammation and Infectious Complications After Resection of Colorectal Liver Metastases
2011
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs
2010 Standout
Cancer to bone: a fatal attraction
2011 Standout
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition
2012
Bortezomib inhibits human osteoclastogenesis
2007
Structure and function of the blood–brain barrier
2009 Standout
Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma
2007
Role of C-Reactive Protein at Sites of Inflammation and Infection
2018 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
New Insights into the Biology of Renal Cell Carcinoma
2011 StandoutNobel
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Ocular Drug Delivery
2010 Standout
Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6
2008
Coordinated regulation of myeloid cells by tumours
2012 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
2008 Standout
Osteoporosis: now and the future
2011 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Skeletal remodeling in health and disease
2007 Standout
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Inflammation and Colon Cancer
2010 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Targeting multidrug resistance in cancer
2006 Standout
Wnt/β-Catenin Signaling and Disease
2012 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Microfluidic organs-on-chips
2014 Standout
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
2009
The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma
2003
Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells
2013
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
2012 Standout
Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases
2008
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
2009 Standout
The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis
2011
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
2006
Mechanisms of Bone Metastasis
2004 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Cancer-related inflammation
2008 StandoutNature
Skeletal and extraskeletal actions of denosumab
2012
Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
2011
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
2009
CD28-mediated regulation of multiple myeloma cell proliferation and survival
2007
Pentraxins: Structure, Function, and Role in Inflammation
2013
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
2006
Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model
2009
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion
2004
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Cancer Genome Landscapes
2013 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Advances in biology of multiple myeloma: clinical applications
2004
Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice
2007
Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics
2006
ABCC Drug Efflux Pumps and Organic Anion Uptake Transporters in Human Gliomas and the Blood-Tumor Barrier
2005
Multiple Myeloma
2011 Standout
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug–induced apoptosis
2009
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
2006
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2
2005
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Works of Michele Wezeman being referenced
Expression of MRP4 Confers Resistance to Ganciclovir and Compromises Bystander Cell Killing
2002
Targeting β2-microglobulin for induction of tumor apoptosis in human hematological malignancies
2006
Human C-Reactive Protein Binds Activating Fcγ Receptors and Protects Myeloma Tumor Cells from Apoptosis
2007
Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.
2006
Cancer and the Microenvironment
2004
Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma
2005
Antimyeloma efficacy of thalidomide in the SCID-hu model
2002